ArticleBreast (Edinburgh, Scotland)2021

Clinicopathological response to neoadjuvant therapies and pathological complete response as a biomarker of survival in human epidermal growth factor receptor-2 enriched breast cancer - A retrospective cohort study.

Matthew G Davey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.